Detalhe da pesquisa
1.
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer.
Oncologist
; 28(2): 123-130, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36495309
2.
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat
; 202(1): 191-201, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37589839
3.
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.
N Engl J Med
; 380(8): 741-751, 2019 02 21.
Artigo
Inglês
| MEDLINE | ID: mdl-30786188
4.
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
JAMA
; 327(20): 1963-1973, 2022 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35608580
5.
Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer.
Int J Mol Sci
; 22(10)2021 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34069042
6.
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Breast Cancer Res Treat
; 181(3): 623-633, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32378051
7.
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer.
Breast Cancer Res Treat
; 178(1): 121-133, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-31368034
8.
Surgical Findings and Outcomes in Premenopausal Breast Cancer Patients Undergoing Oophorectomy: A Multicenter Review From the Society of Gynecologic Surgeons Fellows Pelvic Research Network.
J Minim Invasive Gynecol
; 25(1): 111-115, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28821472
9.
Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.
Eur J Nucl Med Mol Imaging
; 43(13): 2374-2380, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27557845
10.
Subtyping of triple-negative breast cancer: implications for therapy.
Cancer
; 121(1): 8-16, 2015 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25043972
11.
Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel.
Oncologist
; 19(6): 616-22, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24797823
12.
Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling.
Breast Cancer Res Treat
; 145(2): 389-99, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24722917
13.
DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.
Magn Reson Med
; 71(4): 1592-602, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23661583
14.
Feasibility and Tolerability of Adjuvant Capecitabine-Based Chemoradiation in Patients With Breast Cancer and Residual Disease After Neoadjuvant Chemotherapy: A Prospective Clinical Trial.
Int J Radiat Oncol Biol Phys
; 118(5): 1262-1270, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37433376
15.
Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 10(2): 193-201, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38095878
16.
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.
Cancer Discov
; 14(2): 290-307, 2024 Feb 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37791898
17.
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).
Res Sq
; 2024 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38746356
18.
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.
Cancer Res Commun
; 4(4): 1120-1134, 2024 Apr 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38687247
19.
Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
Cancer
; 119(13): 2375-82, 2013 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23575918
20.
Complications of targeted drug therapies for solid malignancies: manifestations and mechanisms.
AJR Am J Roentgenol
; 200(3): 475-83, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23436834